Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer

Although FDG-PET is widely used in cancer, its role in gastric cancer (GC) is still controversial due to variable [Based on a genetic signature, PETscore, representing [Five genes, PLS1, PYY, HBQ1, SLC6A5, and NAT16, were identified for the predictive model for [Our findings suggest that molecular characteristics are underlying the diverse metabolic profiles of GC. Diverse glucose metabolic profiles may apply to precise diagnostic and therapeutic approaches for GC.